Clinical trial
Development of Pancreatic Exocrine Insufficiency After Moderately Severe or Severe Acute Pancreatitis
NCT02563080 is registered in ClinicalTrials.gov with Helsinki University Central Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Development of Pancreatic Exocrine Insufficiency After Moderately Severe or Severe Acute Pancreatitis
- Lead sponsor
- Helsinki University Central Hospital
- Phase
- Observational
- Overall status
- Completed
- Start date
- September 30, 2015
- Completion date
- February 28, 2022
- Enrollment
- 50 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
acute pancreatitis, exocrine pancreatic insufficiency